Cargando…
Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation
Atrial fibrillation (AF) is the most common arrhythmia that requires medical attention, and its incidence is increasing. Current ion channel blockade therapies and catheter ablation have significant limitations in treatment of AF, mainly because they do not address the underlying pathophysiology of...
Autores principales: | Sovari, Ali A., Dudley, Samuel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429082/ https://www.ncbi.nlm.nih.gov/pubmed/22934062 http://dx.doi.org/10.3389/fphys.2012.00311 |
Ejemplares similares
-
Fibrosis in Atrial Fibrillation – Role of Reactive Species and MPO
por: Friedrichs, Kai, et al.
Publicado: (2012) -
Antioxidant Therapy for Atrial Fibrillation: What Is the Next Step?
por: Sovari, Ali A.
Publicado: (2011) -
Reactive oxygen species and redox compartmentalization
por: Kaludercic, Nina, et al.
Publicado: (2014) -
Atrial fibrillation in the elderly: the potential contribution of reactive oxygen species
por: Schillinger, Kurt J., et al.
Publicado: (2012) -
Reactive oxygen species at the crossroads of inflammasome and inflammation
por: Harijith, Anantha, et al.
Publicado: (2014)